Stability characterization, kinetics and mechanism of tacrolimus degradation in cyclodextrin solutions
Tacrolimus is a macrolide lactone and potent immunosuppressant. It is highly lipophilic and has very limited aqueous solubility. Tacrolimus is highly susceptible to hydrolysis which results in very limited stability in aqueous solutions. Besides this, tacrolimus also undergoes dehydration and epimer...
Published in: | International Journal of Pharmaceutics |
---|---|
Main Authors: | , , |
Other Authors: | , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Elsevier
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/20.500.11815/2458 https://doi.org/10.1016/j.ijpharm.2020.119579 |
id |
ftopinvisindi:oai:opinvisindi.is:20.500.11815/2458 |
---|---|
record_format |
openpolar |
spelling |
ftopinvisindi:oai:opinvisindi.is:20.500.11815/2458 2023-05-15T16:51:22+02:00 Stability characterization, kinetics and mechanism of tacrolimus degradation in cyclodextrin solutions Prajapati, Manisha Eiríksson, Finnur Freyr Loftsson, Thorsteinn Lyfjafræðideild (HÍ) Faculty of Pharmaceutical Sciences (UI) Heilbrigðisvísindasvið (HÍ) School of Health Sciences (UI) Háskóli Íslands University of Iceland 2020 https://hdl.handle.net/20.500.11815/2458 https://doi.org/10.1016/j.ijpharm.2020.119579 en eng Elsevier info:eu-repo/grantAgreement/EC/H2020/765441 International Journal of Pharmaceutics;Volume 586, 2020, 119579 Prajapati, M., Eiriksson, F. F., & Loftsson, T. (2020). Stability characterization, kinetics and mechanism of tacrolimus degradation in cyclodextrin solutions. International Journal of Pharmaceutics, 586, 119579. doi:https://doi.org/10.1016/j.ijpharm.2020.119579 0378-5173 https://hdl.handle.net/20.500.11815/2458 International Journal of Pharmaceutics doi:10.1016/j.ijpharm.2020.119579 info:eu-repo/semantics/openAccess Cyclodextrins Tacrolimus Stability Solubility Kinetics Sýklódextrín Lyfjaefnafræði info:eu-repo/semantics/article 2020 ftopinvisindi https://doi.org/20.500.11815/2458 https://doi.org/10.1016/j.ijpharm.2020.119579 2022-11-18T06:52:08Z Tacrolimus is a macrolide lactone and potent immunosuppressant. It is highly lipophilic and has very limited aqueous solubility. Tacrolimus is highly susceptible to hydrolysis which results in very limited stability in aqueous solutions. Besides this, tacrolimus also undergoes dehydration and epimerization. Cyclodextrin (CD) complexation can increase the solubility and stability of hydrophobic drugs in aqueous solutions through the formation of drug/CD complexes. The aim of this study was to investigate degradation kinetics, mechanism and stability of tacrolimus in aqueous CD solutions, with the ultimate goal of developing an aqueous vehicle for ophthalmic delivery. For this, phase-solubility and kinetic studies in aqueous solutions containing different CDs at different pH values were performed. Mass spectrometry studies were also performed to elucidate the degradation mechanism of the drug in aqueous CD solution. The study showed that the drug has maximum stability between pH 4 and 6 and hydrolysis was the main cause of tacrolimus degradation in aqueous 2-hydroxypropyl-βCD (HPβCD) solutions. βCD and its derivatives were the better CD solubilizers for tacrolimus. The solubility and stability studies were further conducted with CD and surfactants, which is tyloxapol, tween 80 and poloxamer 407, where the combination provided better results compared to individual components. This work was financially supported by the European Union grant no. MSCA-ITN-2017-765441 (transMed) and Faculty of Pharmaceutical Sciences, University of Iceland. Special thanks to Master students Ana Teresa Ferreira Nakov and Beatriz Maria Velez Alves for their help in the lab. Article in Journal/Newspaper Iceland Opin vísindi (Iceland) Ferreira ENVELOPE(-62.050,-62.050,-64.600,-64.600) International Journal of Pharmaceutics 586 119579 |
institution |
Open Polar |
collection |
Opin vísindi (Iceland) |
op_collection_id |
ftopinvisindi |
language |
English |
topic |
Cyclodextrins Tacrolimus Stability Solubility Kinetics Sýklódextrín Lyfjaefnafræði |
spellingShingle |
Cyclodextrins Tacrolimus Stability Solubility Kinetics Sýklódextrín Lyfjaefnafræði Prajapati, Manisha Eiríksson, Finnur Freyr Loftsson, Thorsteinn Stability characterization, kinetics and mechanism of tacrolimus degradation in cyclodextrin solutions |
topic_facet |
Cyclodextrins Tacrolimus Stability Solubility Kinetics Sýklódextrín Lyfjaefnafræði |
description |
Tacrolimus is a macrolide lactone and potent immunosuppressant. It is highly lipophilic and has very limited aqueous solubility. Tacrolimus is highly susceptible to hydrolysis which results in very limited stability in aqueous solutions. Besides this, tacrolimus also undergoes dehydration and epimerization. Cyclodextrin (CD) complexation can increase the solubility and stability of hydrophobic drugs in aqueous solutions through the formation of drug/CD complexes. The aim of this study was to investigate degradation kinetics, mechanism and stability of tacrolimus in aqueous CD solutions, with the ultimate goal of developing an aqueous vehicle for ophthalmic delivery. For this, phase-solubility and kinetic studies in aqueous solutions containing different CDs at different pH values were performed. Mass spectrometry studies were also performed to elucidate the degradation mechanism of the drug in aqueous CD solution. The study showed that the drug has maximum stability between pH 4 and 6 and hydrolysis was the main cause of tacrolimus degradation in aqueous 2-hydroxypropyl-βCD (HPβCD) solutions. βCD and its derivatives were the better CD solubilizers for tacrolimus. The solubility and stability studies were further conducted with CD and surfactants, which is tyloxapol, tween 80 and poloxamer 407, where the combination provided better results compared to individual components. This work was financially supported by the European Union grant no. MSCA-ITN-2017-765441 (transMed) and Faculty of Pharmaceutical Sciences, University of Iceland. Special thanks to Master students Ana Teresa Ferreira Nakov and Beatriz Maria Velez Alves for their help in the lab. |
author2 |
Lyfjafræðideild (HÍ) Faculty of Pharmaceutical Sciences (UI) Heilbrigðisvísindasvið (HÍ) School of Health Sciences (UI) Háskóli Íslands University of Iceland |
format |
Article in Journal/Newspaper |
author |
Prajapati, Manisha Eiríksson, Finnur Freyr Loftsson, Thorsteinn |
author_facet |
Prajapati, Manisha Eiríksson, Finnur Freyr Loftsson, Thorsteinn |
author_sort |
Prajapati, Manisha |
title |
Stability characterization, kinetics and mechanism of tacrolimus degradation in cyclodextrin solutions |
title_short |
Stability characterization, kinetics and mechanism of tacrolimus degradation in cyclodextrin solutions |
title_full |
Stability characterization, kinetics and mechanism of tacrolimus degradation in cyclodextrin solutions |
title_fullStr |
Stability characterization, kinetics and mechanism of tacrolimus degradation in cyclodextrin solutions |
title_full_unstemmed |
Stability characterization, kinetics and mechanism of tacrolimus degradation in cyclodextrin solutions |
title_sort |
stability characterization, kinetics and mechanism of tacrolimus degradation in cyclodextrin solutions |
publisher |
Elsevier |
publishDate |
2020 |
url |
https://hdl.handle.net/20.500.11815/2458 https://doi.org/10.1016/j.ijpharm.2020.119579 |
long_lat |
ENVELOPE(-62.050,-62.050,-64.600,-64.600) |
geographic |
Ferreira |
geographic_facet |
Ferreira |
genre |
Iceland |
genre_facet |
Iceland |
op_relation |
info:eu-repo/grantAgreement/EC/H2020/765441 International Journal of Pharmaceutics;Volume 586, 2020, 119579 Prajapati, M., Eiriksson, F. F., & Loftsson, T. (2020). Stability characterization, kinetics and mechanism of tacrolimus degradation in cyclodextrin solutions. International Journal of Pharmaceutics, 586, 119579. doi:https://doi.org/10.1016/j.ijpharm.2020.119579 0378-5173 https://hdl.handle.net/20.500.11815/2458 International Journal of Pharmaceutics doi:10.1016/j.ijpharm.2020.119579 |
op_rights |
info:eu-repo/semantics/openAccess |
op_doi |
https://doi.org/20.500.11815/2458 https://doi.org/10.1016/j.ijpharm.2020.119579 |
container_title |
International Journal of Pharmaceutics |
container_volume |
586 |
container_start_page |
119579 |
_version_ |
1766041479714701312 |